These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32484293)

  • 1. Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.
    Yekula A; Muralidharan K; Rosh ZS; Youngkin AE; Kang KM; Balaj L; Carter BS
    Adv Biosyst; 2020 Dec; 4(12):e2000029. PubMed ID: 32484293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
    Strauss SB; Meng A; Ebani EJ; Chiang GC
    Radiol Clin North Am; 2019 Nov; 57(6):1199-1216. PubMed ID: 31582045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy for brain tumors.
    Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
    Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Circulating Biomarkers of Brain Tumors.
    Jelski W; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating biomarkers in patients with glioblastoma.
    Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
    Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy.
    Garcia CM; Toms SA
    World Neurosurg; 2020 Jun; 138():425-435. PubMed ID: 32251831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum liquid biopsy for brain tumours: a scoping analysis of practicable approaches in low- and middle-income countries.
    Bajwa MH; Khan MA; Urooj F; Khalid MU; Enam SA; Aziz HF; Siddiqui K; Bari ME; Mughal N
    J Pak Med Assoc; 2024 Mar; 74(3 (Supple-3)):S30-S51. PubMed ID: 39262064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Liquid Biopsies in Pediatric Brain Tumors.
    Tang K; Gardner S; Snuderl M
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
    Soler DC; Kerstetter-Fogle A; Elder T; Raghavan A; Barnholtz-Sloan JS; Cooper KD; McCormick TS; Sloan AE
    Neurosurgery; 2020 Dec; 88(1):E67-E72. PubMed ID: 32823285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
    Ricklefs FL; Wollmann K; Salviano-Silva A; Drexler R; Maire CL; Kaul MG; Reimer R; Schüller U; Heinemann S; Kolbe K; Mummert T; Glatzel M; Peine S; Gempt J; Westphal M; Dührsen L; Lamszus K
    Neuro Oncol; 2024 Jul; 26(7):1280-1291. PubMed ID: 38567448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors.
    Mathios D; Srivastava S; Kim T; Bettegowda C; Lim M
    Neuromolecular Med; 2022 Jun; 24(2):74-87. PubMed ID: 34297308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
    Birkó Z; Nagy B; Klekner Á; Virga J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053907
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
    Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Circulating Biomarkers in Patients with Glioblastoma.
    Senhaji N; Squalli Houssaini A; Lamrabet S; Louati S; Bennis S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
    Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
    ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.
    Kamińska P; Buszka K; Zabel M; Nowicki M; Alix-Panabières C; Budna-Tukan J
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
    Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
    J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.